Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amgen

290.33
+3.231.13%
Pre-market: 289.60-0.7300-0.25%08:55 EDT
Volume:2.00M
Turnover:580.21M
Market Cap:156.11B
PE:26.53
High:293.57
Open:289.80
Low:289.01
Close:287.10
Loading ...

Switzerland's Sandoz files antitrust lawsuit against Amgen in US

Reuters
·
14 Apr

BRIEF-Sandoz Files Antitrust Litigation Against Amgen In The US

Reuters
·
14 Apr

Sandoz Files Antitrust Litigation Against Amgen Regarding Patient Access to Etanercept Biosimilar in the US

THOMSON REUTERS
·
14 Apr

Sandoz Group Ag - Seeks Triple Damages in Antitrust Lawsuit

THOMSON REUTERS
·
14 Apr

Sandoz Group Ag - Alleges Amgen Blocked Biosimilar Competition

THOMSON REUTERS
·
14 Apr

Amgen Has A Growth Plan in Its Pocket. Buy The Stock. -- Barron's

Dow Jones
·
12 Apr

Amgen (AMGN) Gains But Lags Market: What You Should Know

Zacks
·
12 Apr

Amgen Inc. Stock Rises Friday, Still Underperforms Market

Dow Jones
·
12 Apr

Amgen (NasdaqGS:AMGN) Clinical Trial Success In SCLC Treatment With IMDELLTRA

Simply Wall St.
·
12 Apr

Citigroup Adjusts Price Target on Amgen to $290 From $295, Keeps Neutral Rating

MT Newswires Live
·
11 Apr

US FDA Animal Testing De-Emphasis May Boost Biotech Innovation, RBC Says

MT Newswires Live
·
11 Apr

BRIEF-Imdelltra® Demonstrated Superior Overall Survival In Small Cell Lung Cancer

Reuters
·
11 Apr

Amgen Says Phase 3 Trial of Lung Cancer Drug Imdelltra Met Primary Endpoint at Interim

MT Newswires Live
·
11 Apr

Amgen Inc: Global Phase 3 Dellphi-304 Clinical Trial Met Its Primary Endpoint at a Planned Interim Analysis

THOMSON REUTERS
·
11 Apr

Amgen: Imdelltra Showed Statistically Significant and Clinically Meaningful Improvement in Os VS Local Standard-of-Care Chemotherapy

THOMSON REUTERS
·
11 Apr

IMDELLTRA® DEMONSTRATED SUPERIOR OVERALL SURVIVAL IN SMALL CELL LUNG CANCER

PR Newswire
·
11 Apr

Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM) and Amgen (AMGN)

TIPRANKS
·
11 Apr

Dow's 965-Point Fall Led By Losses In Shares Of Nike, Walt Disney

Dow Jones
·
10 Apr

Amgen Is Getting Into the Obesity Drug Business. Buy the Stock Before It Becomes the Next Winner. -- Barrons.com

Dow Jones
·
10 Apr

Biotech Stock Roundup: PCRX Up on Patent News, EWTX Down on Study Data & More

Zacks
·
10 Apr